Back
Ultragenyx Pharmaceutical Stock Price Chart
Sponsored
RARE
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RARE
Ultragenyx Pharmaceutical
Last Price:
46.00
Seasonality Move:
12.78%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.86 | Sell |
20-day SMA: | 49.89 | Sell |
50-day SMA: | 53.59 | Sell |
200-day SMA: | 48.05 | Sell |
8-day EMA: | 46.79 | Sell |
20-day EMA: | 49.27 | Sell |
50-day EMA: | 51.47 | Sell |
200-day EMA: | 48.74 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.33 | Sell |
Relative Strength Index (14 RSI): | 35.6 | Sell |
Chaikin Money Flow: | 283795 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.45 - 54.59) | Sell |
Bollinger Bands (100): | (45.99 - 56.73) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 46.40 while RARE 8-day simple moving average is 46.86, which is a Sell signal.
- The stock price of RARE is 46.40 while Ultragenyx Pharmaceutical 20-day SMA is 49.89, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 53.59 while RARE share price is 46.40, making it a Sell technically.
- RARE stock price is 46.40 and Ultragenyx Pharmaceutical 200-day simple moving average is 48.05, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
28
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $46.40. The Score for RARE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
4.28B
Price in USD:
46.40
Share Volume:
641.62K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
37.02
Sell
28
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 46.40 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 46.40 while RARE 8-day exponential moving average is 46.79, which is a Sell signal.
- The stock price of RARE is 46.40 while Ultragenyx Pharmaceutical 20-day EMA is 49.27, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 51.47 while RARE share price is 46.40, making it a Sell technically.
- RARE stock price is 46.40 and Ultragenyx Pharmaceutical 200-day simple moving average is 48.74, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $1.08 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -2.33, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 35.6, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (47.45 - 54.59), which suggest Ultragenyx Pharmaceutical is a Sell
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (45.99 - 56.73), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.